Profile
Colin J. Meyer is Chief Research & Development Officer, Executive VP at Reata Pharmaceuticals, Inc. He received an undergraduate degree from the University of Virginia, a doctorate from The University of Texas Southwestern Medical Center and an MBA from SMU-Cox School of Business.
Former positions of Colin Meyer
| Companies | Position | End |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-02-06 |
Training of Colin Meyer
| University of Virginia | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| SMU-Cox School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Stock Market
- Insiders
- Colin Meyer
